Actinogen Medical (ASX: ACW)

Actinogen Medical (ASX: ACW) is a clinical-stage biotechnology company undertaking a focused and differentiated approach for treating cognitive impairment in chronic neurodegenerative diseases through the inhibition of cortisol production. www.actinogen.com.au

Actinogen Medical ASX ACW cognitive improvement Xanamem XanaHES Alzheimer’s disease neurological

Actinogen Medical announces ‘breakthrough’ study results for Alzheimer’s drug Xanamem

Actinogen Medical (ASX: ACW) has announced “breakthrough” results from its XanaHES higher dose safety study first initiated last year. The re...
Actinogen Medical ASX ACW Phase 2 Alzheimer's disease trial results fail dementia

Actinogen Medical phase two Alzheimer’s clinical trial disappoints

Biotech company Actinogen Medical (ASX: ACW) has reported a mixed bag of results including some disappointing outcomes from its XanADu phase two...
Actinogen Medical ASX ACW US biotech investor Alzheimer’s XanADu study

Actinogen Medical attracts US biotech investor as Alzheimer’s XanADu study remains on track

Actinogen Medical (ASX: ACW) has received a double-shot of positive news earlier today after the biotech company received the all-clear from the...
Actinogen Medical ASX ACW XanADu treat Alzheimer’s disease

Actinogen moves towards XanADu starting line to treat Alzheimer’s disease

Biotech company Actinogen Medical (ASX: ACW) has confirmed that it has obtained half of the required patients in order to conduct its landmark P...
Small Caps ASX Australian stock market
Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
Copyright 2020 Small Caps. All rights reserved.